239 related articles for article (PubMed ID: 26900675)
1. PREVALENCE OF MYD88 L265P MUTATION IN HISTOLOGICALLY PROVEN, DIFFUSE LARGE B-CELL VITREORETINAL LYMPHOMA.
Raja H; Salomão DR; Viswanatha DS; Pulido JS
Retina; 2016 Mar; 36(3):624-8. PubMed ID: 26900675
[TBL] [Abstract][Full Text] [Related]
2. Clinical Relevance of the High Prevalence of MYD88 L265P Mutated Vitreoretinal Lymphoma Identified by Droplet Digital Polymerase Chain Reaction.
Shi H; Zhou X; Chen B; Xiao J; Li Y; Zhou X; Zhou Q; Chen K; Wang Q
Ocul Immunol Inflamm; 2021 Apr; 29(3):448-455. PubMed ID: 31603365
[No Abstract] [Full Text] [Related]
3. MyD-88 L265P mutations are present in some cases of vitreoretinal lymphoma.
Pulido JS; Salomao DR; Frederick LA; Viswanatha DS
Retina; 2015 Apr; 35(4):624-7. PubMed ID: 25768255
[TBL] [Abstract][Full Text] [Related]
4. Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction.
Hiemcke-Jiwa LS; Ten Dam-van Loon NH; Leguit RJ; Nierkens S; Ossewaarde-van Norel J; de Boer JH; Roholl FF; de Weger RA; Huibers MMH; de Groot-Mijnes JDF; Kuiper JJW
JAMA Ophthalmol; 2018 Oct; 136(10):1098-1104. PubMed ID: 30027272
[TBL] [Abstract][Full Text] [Related]
5. Single B-Cell Genomic Analyses Differentiate Vitreoretinal Lymphoma from Chronic Inflammation.
Tan WJ; Wang MM; Castagnoli PR; Tang T; Chan ASY; Lim TS
Ophthalmology; 2021 Jul; 128(7):1079-1090. PubMed ID: 33221324
[TBL] [Abstract][Full Text] [Related]
6. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
[TBL] [Abstract][Full Text] [Related]
7. MYD88 expression and L265P mutation in diffuse large B-cell lymphoma.
Choi JW; Kim Y; Lee JH; Kim YS
Hum Pathol; 2013 Jul; 44(7):1375-81. PubMed ID: 23380077
[TBL] [Abstract][Full Text] [Related]
8. MYD88 L265P MUTATION DETECTION IN THE AQUEOUS HUMOR OF PATIENTS WITH VITREORETINAL LYMPHOMA.
Miserocchi E; Ferreri AJM; Giuffrè C; Cangi MG; Francaviglia I; Calimeri T; Ponzoni M; Pecciarini L; Bandello FM; Modorati GM
Retina; 2019 Apr; 39(4):679-684. PubMed ID: 30204732
[TBL] [Abstract][Full Text] [Related]
9. PreservCyt Is an Optimal Fixative that Permits Cytologic and Molecular Analyses of Vitreoretinal Lymphoma Biopsies.
Wang MM; Tan WJ; Lim TS; Chan ASY
Ocul Immunol Inflamm; 2021 Apr; 29(3):430-439. PubMed ID: 31418635
[No Abstract] [Full Text] [Related]
10. Frequent MYD88 L265P and CD79B Mutations in Primary Breast Diffuse Large B-Cell Lymphoma.
Taniguchi K; Takata K; Chuang SS; Miyata-Takata T; Sato Y; Satou A; Hashimoto Y; Tamura M; Nagakita K; Ohnishi N; Noujima-Harada M; Tabata T; Kikuti YY; Maeda Y; Nakamura N; Tanimoto M; Yoshino T
Am J Surg Pathol; 2016 Mar; 40(3):324-34. PubMed ID: 26752547
[TBL] [Abstract][Full Text] [Related]
11. High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B-cell lymphoma, leg-type.
Pham-Ledard A; Beylot-Barry M; Barbe C; Leduc M; Petrella T; Vergier B; Martinez F; Cappellen D; Merlio JP; Grange F
JAMA Dermatol; 2014 Nov; 150(11):1173-9. PubMed ID: 25055137
[TBL] [Abstract][Full Text] [Related]
12. Clinical spectrum of vitreoretinal lymphoma and its association with MyD88 L265P mutation.
Carreno E; Clench T; Steeples LR; Salvatore S; Lee RWJ; Dick AD; Pawade J
Acta Ophthalmol; 2019 Feb; 97(1):e138-e139. PubMed ID: 30113125
[No Abstract] [Full Text] [Related]
13. Cytological diagnosis of vitreoretinal lymphomas: A case series.
Quintyn JC; Olle P; Courtade-Saidi M; Laurent C; Obéric L; Quintyn-Ranty ML
Cytopathology; 2019 Jul; 30(4):385-392. PubMed ID: 31033057
[TBL] [Abstract][Full Text] [Related]
14. High frequency of MYD88 mutations in vitreoretinal B-cell lymphoma: a valuable tool to improve diagnostic yield of vitreous aspirates.
Bonzheim I; Giese S; Deuter C; Süsskind D; Zierhut M; Waizel M; Szurman P; Federmann B; Schmidt J; Quintanilla-Martinez L; Coupland SE; Bartz-Schmidt KU; Fend F
Blood; 2015 Jul; 126(1):76-9. PubMed ID: 25900979
[TBL] [Abstract][Full Text] [Related]
15. Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center.
Giuffrè C; Cicinelli MV; Marchese A; Modorati GM; Brambati M; Ferreri AJM; Calimeri T; Ponzoni M; Bandello F; Miserocchi E
Ocul Immunol Inflamm; 2021 Apr; 29(3):472-478. PubMed ID: 32845738
[No Abstract] [Full Text] [Related]
16. Aqueous Humor-Derived MYD88 L265P Mutation Analysis in Vitreoretinal Lymphoma: A Potential Less Invasive Method for Diagnosis and Treatment Response Assessment.
Demirci H; Rao RC; Elner VM; Demirci FY; Axenov L; Betz B; Behdad A; Brown N
Ophthalmol Retina; 2023 Feb; 7(2):189-195. PubMed ID: 35952929
[TBL] [Abstract][Full Text] [Related]
17. MYD88 L265P mutation detected by digital PCR as a prognostic factor in patients with diffuse large B-cell lymphoma in rituximab era.
Nishimura N; Takeuchi K; Asaka R; Tuyama N; Inoue N; Kusano Y; Mishima Y; Yokoyama M; Terui Y
Leuk Res; 2020 Oct; 97():106426. PubMed ID: 32781214
[TBL] [Abstract][Full Text] [Related]
18. Next-Generation Sequencing of Vitreoretinal Lymphoma by Vitreous Liquid Biopsy: Diagnostic Potential and Genotype/Phenotype Correlation.
Kwak JJ; Lee KS; Lee J; Kim YJ; Choi EY; Byeon SH; Chang WS; Kim YR; Kim JS; Shin S; Lee ST; Kim SS; Lee CS
Invest Ophthalmol Vis Sci; 2023 Nov; 64(14):27. PubMed ID: 37975847
[TBL] [Abstract][Full Text] [Related]
19. MYD88 expression and L265P mutation in mature B-cell non-Hodgkin lymphomas.
Caner V; Sen Turk N; Baris IC; Cetin GO; Tepeli E; Hacioglu S; Sari I; Zencir S; Dogu MH; Bagci G; Keskin A
Genet Test Mol Biomarkers; 2015 Jul; 19(7):372-8. PubMed ID: 25978699
[TBL] [Abstract][Full Text] [Related]
20.
Narasimhan S; Joshi M; Parameswaran S; Rishi P; Khetan V; Ganesan S; Biswas J; Sundaram N; Sreenivasan J; Verma S; Krishnamurthy V; Subramanian K
Indian J Ophthalmol; 2020 Oct; 68(10):2160-2165. PubMed ID: 32971631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]